{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:15:59Z","timestamp":1788196559146,"version":"build-2803163510"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,12]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      This study aimed to explore the diagnostic value of combining serologic indexes with the Gleason score (GS) in identifying prostate cancer bone metastasis. We included 108 patients diagnosed with prostate cancer at the Third Hospital of Mianyang from December 2019 to December 2021. Clinical data were collected, and patients were divided into 2 groups: 44 cases with prostate cancer bone metastasis and 64 cases without bone metastasis. We compared age, serum total prostate-specific antigen (TPSA), free prostate-specific antigen (FPSA), fibrinogen (FIB), alkaline phosphatase (ALP), serum albumin (ALB), and GS between the 2 groups. Logistic regression analysis was used to assess the correlation between serologic indexes and prostate cancer bone metastasis. The diagnostic value of combining multiple indexes versus single indexes was evaluated using receiver operating characteristic curves. The serum TPSA, FPSA, FIB, ALP and GS levels of patients in the prostate cancer bone metastasis group were higher than those of patients in the prostate cancer without bone metastasis group, while the ALB level in the bone metastasis group was lower than that in the non-bone metastasis group. The differences in each index were statistically significant when compared between the 2 groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). The univariate logistic analysis revealed that TPSA (\n                      <jats:italic toggle=\"yes\">OR<\/jats:italic>\n                      :0.984,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), FPSA (\n                      <jats:italic toggle=\"yes\">OR<\/jats:italic>\n                      :0.899,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), ALP (\n                      <jats:italic toggle=\"yes\">OR<\/jats:italic>\n                      :0.986,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05), and GS (\n                      <jats:italic toggle=\"yes\">OR<\/jats:italic>\n                      :0.569,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05) were positively correlated with prostate cancer bone metastasis. Multivariate analysis showed that ALP (\n                      <jats:italic toggle=\"yes\">OR<\/jats:italic>\n                      \u2005=\u20050.991,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05) was an independent risk factor for bone metastasis in prostate cancer after adjusting for Age, ALB, and FIB. The area under the receiver operating characteristic curve (AUC) of serum ALP and the combined assay were 0.738 and 0.792, respectively. Serum TPSA, FPSA, FIB, ALB, ALP and GS have significant diagnostic value in identifying prostate cancer bone metastasis. ALP is an independent risk factor for bone metastasis in prostate cancer. Combining these indicators can enhance diagnostic efficacy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049298","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:00:10Z","timestamp":1781600410000},"page":"e49298","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic value of serologic indexes combined with Gleason score in bone metastases of prostate cancer"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2169-7145","authenticated-orcid":false,"given":"Yuexi","family":"Kang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Echocardiography, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinping","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renfei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Dang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260831","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","article-title":"Recent patterns and trends in global prostate cancer incidence and mortality: an update.","volume":"87","author":"Schafer","year":"2025","journal-title":"Eur Urol"},{"key":"R2-20260831","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/j.semnuclmed.2023.07.004","article-title":"Bone metastasis in prostate cancer: bone scan versus PET imaging.","volume":"54","author":"Mohseninia","year":"2024","journal-title":"Semin Nucl Med"},{"key":"R3-20260831","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2024.13806","article-title":"PSA screening and prostate cancer mortality.","volume":"332","author":"Goldstein","year":"2024","journal-title":"JAMA"},{"key":"R4-20260831","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3390\/jcm14041326","article-title":"The predictive role of the gleason score in determining prognosis to systematic treatment in metastatic castration-sensitive prostate cancer: a systematic review and network meta-analysis.","volume":"14","author":"Wu","year":"2025","journal-title":"J Clin Med"},{"key":"R5-20260831","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.pan.2020.06.010","article-title":"Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.","volume":"20","author":"Chung","year":"2020","journal-title":"Pancreatology"},{"key":"R6-20260831","doi-asserted-by":"crossref","first-page":"9462","DOI":"10.1038\/s41598-025-93056-8","article-title":"FDP\/FIB ratio serves as a novel biomarker for diagnosing bone marrow invasion in gastric cancer and predicting patient prognosis.","volume":"15","author":"Yan","year":"2025","journal-title":"Sci Rep"},{"key":"R7-20260831","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer.","volume":"4","author":"Gandaglia","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"R8-20260831","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/liv.15115","article-title":"Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma.","volume":"42","author":"Fu","year":"2022","journal-title":"Liver Int"},{"key":"R9-20260831","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jcsm.12906","article-title":"Serum carnitine as a biomarker of sarcopenia and nutritional status in preoperative gastrointestinal cancer patients.","volume":"13","author":"Takagi","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R10-20260831","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s42452-024-05727-2","article-title":"Comprehensive modelling of prostate cancer progression: integrating continuous and binary biomarkers with event time data and missing covariates.","volume":"6","author":"Liaqat","year":"2024","journal-title":"Discover Appl Sci"},{"key":"R11-20260831","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1039\/D3MD00565H","article-title":"Emerging potential approaches in alkaline phosphatase (ALP) activatable cancer theranostics.","volume":"15","author":"Tyagi","year":"2024","journal-title":"RSC Med Chem"},{"key":"R12-20260831","doi-asserted-by":"crossref","first-page":"e37526","DOI":"10.1097\/MD.0000000000037526","article-title":"The association between serum albumin and alkaline phosphatase in cancer patients.","volume":"103","author":"Jiang","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"R13-20260831","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/jpm13050705","article-title":"Biomarkers for prostate cancer bone metastasis detection and prediction.","volume":"13","author":"Ying","year":"2023","journal-title":"J Pers Med"},{"key":"R14-20260831","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13046-024-03235-0","article-title":"Ferroptosis and the tumor microenvironment.","volume":"43","author":"Cui","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"R15-20260831","first-page":"12","article-title":"Cancer statistics, 2024.","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R16-20260831","doi-asserted-by":"crossref","first-page":"pkae109","DOI":"10.1093\/jncics\/pkae109","article-title":"County-level racial disparities in prostate cancer\u2013specific mortality from 2005 to 2020.","volume":"8","author":"Washington Iii","year":"2024","journal-title":"JNCI Cancer Spectrum"},{"key":"R17-20260831","first-page":"1393456126","article-title":"Magnetic resonance or computed tomography and bone scan for staging metastatic hormone\u2013sensitive prostate cancer.","volume":"19","author":"Hassan","year":"2025","journal-title":"Clin Med Insights"},{"key":"R18-20260831","doi-asserted-by":"crossref","first-page":"208","DOI":"10.7150\/ijbs.27537","article-title":"Establishing a prediction model for prostate cancer bone metastasis.","volume":"15","author":"Chen","year":"2019","journal-title":"Int J Biol Sci"},{"key":"R19-20260831","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.12659\/MSM.900977","article-title":"Associations of prostate-specific antigen, prostate carcinoma tissue gleason score, and androgen receptor expression with bone metastasis in patients with prostate carcinoma.","volume":"23","author":"Chen","year":"2017","journal-title":"Med Sci Monit"},{"key":"R20-20260831","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.urology.2014.06.010","article-title":"Toward better use of bone scans among men with early-stage prostate cancer.","volume":"84","author":"Merdan","year":"2014","journal-title":"Urology"},{"key":"R21-20260831","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1073\/pnas.83.10.3166","article-title":"Human prostate-specific antigen: structural and functional similarity with serine proteases.","volume":"83","author":"Watt","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-20260831","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.3390\/ijms26104669","article-title":"Pilot investigation on markers of bone metabolism, angiogenesis, and neuroendocrine activity as potential predictors of survival of metastatic prostate cancer patients with bone metastases.","volume":"26","author":"Ortiz","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R23-20260831","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.trecan.2023.06.003","article-title":"Diet, nutrient supply, and tumor immune responses.","volume":"9","author":"Mcintyre","year":"2023","journal-title":"Trends Cancer"},{"key":"R24-20260831","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.prnil.2017.05.001","article-title":"Fibrinogen and D-dimer levels in prostate cancer: preliminary results.","volume":"5","author":"\u00c7ali\u015fkan","year":"2017","journal-title":"Prostate Int"},{"key":"R25-20260831","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00223-022-01048-x","article-title":"Alkaline phosphatases: biochemistry, functions, and measurement.","volume":"112","author":"Makris","year":"2023","journal-title":"Calcif Tissue Int"},{"key":"R26-20260831","doi-asserted-by":"crossref","first-page":"gmr.15027707","DOI":"10.4238\/gmr.15027707","article-title":"Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer patients and the significance of ROC curve in the diagnosis of prostate cancer bone metastases.","volume":"15","author":"Wei","year":"2016","journal-title":"Genet Mol Res"},{"key":"R27-20260831","first-page":"403","article-title":"Identification of clinically significant prostate cancer by combined PCA3 and AMACR mRNA detection in urine samples.","volume":"12","author":"Kotova","year":"2020","journal-title":"Res Rep Urol"},{"key":"R28-20260831","first-page":"391","article-title":"Risk factors of bone metastasis in patients with newly diagnosed prostate cancer.","volume":"26","author":"Chaoying","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R29-20260831","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.transproceed.2017.03.006","article-title":"Prostate cancer in renal transplant recipients: diagnosis and treatment.","volume":"49","author":"Carvalho","year":"2017","journal-title":"Transplant Proc"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:00:35Z","timestamp":1788195635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":29,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049298","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"2024-09-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}